| Literature DB >> 30201809 |
Jennie A Hamilton1, Qi Wu1, PingAr Yang1, Bao Luo1, Shanrun Liu1, Jun Li1, Alexa L Mattheyses2, Ignacio Sanz3, W Winn Chatham1, Hui-Chen Hsu1, John D Mountz4,5.
Abstract
In systemic lupus erythematosus (SLE), type I IFNs promote induction of type I IFN-stimulated genes (ISG) and can drive B cells to produce autoantibodies. Little is known about the expression of distinct type I IFNs in lupus, particularly high-affinity IFN-β. Single-cell analyses of transitional B cells isolated from SLE patients revealed distinct B cell subpopulations, including type I IFN producers, IFN responders, and mixed IFN producer/responder clusters. Anti-Ig plus TLR3 stimulation of SLE B cells induced release of bioactive type I IFNs that could stimulate HEK-Blue cells. Increased levels of IFN-β were detected in circulating B cells from SLE patients compared with controls and were significantly higher in African American patients with renal disease and in patients with autoantibodies. Together, the results identify type I IFN-producing and -responding subpopulations within the SLE B cell compartment and suggest that some patients may benefit from specific targeting of IFN-β.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30201809 PMCID: PMC6230322 DOI: 10.4049/jimmunol.1800791
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422